Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Circulation

Retrieve available abstracts of 86 articles:
HTML format

Single Articles

    November 2022
  1. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
    Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Circulation. 2022;146:1461-1474.
    PubMed     Abstract available

  2. Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022;146:e279.

  3. KANG J, Park KW, Lee H, Hwang D, et al
    Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study.
    Circulation. 2022 Nov 7. doi: 10.1161/CIRCULATIONAHA.122.062770.
    PubMed     Abstract available

  4. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
    A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
    PubMed     Abstract available

  5. WU H, Xu L, Zhao X, Zhang H, et al
    Indobufen or Aspirin on Top of Clopidogrel after Coronary Drug-eluting Stent Implantation (OPTION): a Randomized, Open-label, Endpoint-blinded, Non-inferiority Trial.
    Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062762.
    PubMed     Abstract available

    October 2022
  6. GAZIANO L, Sun L, Arnold M, Bell S, et al
    Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.
    Circulation. 2022 Oct 31. doi: 10.1161/CIRCULATIONAHA.122.060700.
    PubMed     Abstract available

    September 2022
  7. LEVINE GN, McEvoy JW, Fang JC, Ibeh C, et al
    Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Sep 15:101161CIR0000000000001092.
    PubMed     Abstract available

  8. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
    Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
    Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
    PubMed     Abstract available

    August 2022
  9. BOHULA EA, Berg DD, Lopes MS, Connors JM, et al
    Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients with COVID-19: COVID-PACT.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061533.
    PubMed     Abstract available

  10. O'DONOGHUE ML, Giugliano RP, Wiviott SD, Atar D, et al
    Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease.
    Circulation. 2022 Aug 29. doi: 10.1161/CIRCULATIONAHA.122.061620.
    PubMed     Abstract available

  11. RAO SV, Kirsch B, Bhatt DL, Budaj A, et al
    A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes Following Acute Myocardial Infarction.
    Circulation. 2022 Aug 27. doi: 10.1161/CIRCULATIONAHA.122.061612.
    PubMed     Abstract available

  12. JURGENS CY, Lee CS, Aycock DM, Masterson Creber R, et al
    State of the Science: The Relevance of Symptoms in Cardiovascular Disease and Research: A Scientific Statement From the American Heart Association.
    Circulation. 2022 Aug 18:101161CIR0000000000001089.
    PubMed     Abstract available

  13. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
    Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
    PubMed     Abstract available

    July 2022
  14. KUEHN BM
    Nurse Navigators Cut Stroke Readmissions by Half.
    Circulation. 2022;146:140-141.

    Endovascular Therapy for Acute Basilar Artery Occlusion.
    Circulation. 2022;146:18-20.

    June 2022
  16. HAGSTROM E, Steg PG, Szarek M, Bhatt DL, et al
    Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
    Circulation. 2022 Jun 30:101161CIRCULATIONAHA121057807.
    PubMed     Abstract available

  17. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
    Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
    Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
    PubMed     Abstract available

  18. TAO C, Qureshi AI, Yin Y, Li J, et al
    Endovascular Treatment Versus Best Medical Management in Acute Basilar Artery Occlusion Strokes: Results From the ATTENTION Multicenter Registry.
    Circulation. 2022 Jun 3:101161CIRCULATIONAHA121058544.
    PubMed     Abstract available

    April 2022
  19. NATALE A, Kar S, Holmes D
    Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e847-e848.

  20. PRICE MJ, Gibson DN, Kar S
    Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e849.

  21. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
    Circulation. 2022;145:e845-e846.

  22. LUSEBRINK E, Kellnar A, Krieg K, Binzenhofer L, et al
    Percutaneous Transvalvular Microaxial Flow Pump Support in Cardiology.
    Circulation. 2022;145:1254-1284.
    PubMed     Abstract available

  23. VASAN RS, Enserro DM, Xanthakis V, Beiser AS, et al
    Temporal Trends in the Remaining Lifetime Risk of Cardiovascular Disease Among Middle-Aged Adults Across 6 Decades: The Framingham Study.
    Circulation. 2022 Apr 18. doi: 10.1161/CIRCULATIONAHA.121.057889.
    PubMed     Abstract available

  24. SPYROPOULOS AC, Raskob GE, Cohen AT, Ageno W, et al
    Association of Bleeding Severity with Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
    Circulation. 2022 Apr 7. doi: 10.1161/CIRCULATIONAHA.121.057847.
    PubMed     Abstract available

    March 2022
  25. BORLAUG BA, Blair J, Bergmann MW, Bugger H, et al
    Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Circulation. 2022 Mar 31. doi: 10.1161/CIRCULATIONAHA.122.059486.
    PubMed     Abstract available

  26. JOUNDI RA, Sun JL, Xian Y, Alhanti B, et al
    Association Between Endovascular Therapy Time to Treatment and Outcomes in Patients With Basilar Artery Occlusion.
    Circulation. 2022;145:896-905.
    PubMed     Abstract available

  27. LI KC, Huang L, Tian M, Di Tanna GL, et al
    Cost-effectiveness of a Household Salt Substitution Intervention: Findings From 20,995 Participants of the Salt Substitute and Stroke Study (SSaSS).
    Circulation. 2022 Mar 21. doi: 10.1161/CIRCULATIONAHA.122.059573.
    PubMed     Abstract available

  28. KOWALEWSKI C, Dagres N, Hindricks G
    Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
    Circulation. 2022;145:739-741.

  29. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
    Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
    Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
    PubMed     Abstract available

    February 2022
  30. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
    MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
    Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
    PubMed     Abstract available

    January 2022
  31. TSAO CW, Aday AW, Almarzooq ZI, Alonso A, et al
    Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.
    Circulation. 2022 Jan 26:CIR0000000000001052. doi: 10.1161/CIR.0000000000001052.
    PubMed     Abstract available

  32. AGUADO BA, Walker CJ, Grim JC, Schroeder ME, et al
    Genes that Escape X Chromosome Inactivation Modulate Sex Differences in Valve Myofibroblasts.
    Circulation. 2022 Jan 10. doi: 10.1161/CIRCULATIONAHA.121.054108.
    PubMed     Abstract available

    December 2021
  33. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
    Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
    Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
    PubMed     Abstract available

  34. ZHENG F, von Spreckelsen N, Hu W
    Letter by Zheng et al Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e491-e492.

  35. TRIFAN G, Gorelick PB, Testai FD
    Response by Trifan et al to Letter Regarding Article, "Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials".
    Circulation. 2021;144:e493-e494.

    November 2021
    Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
    Circulation. 2021;144:1747-1749.

    In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
    Circulation. 2021;144:1587-1589.

    October 2021
  38. VERMA S, Bhatt DL, Steg PG, Miller M, et al
    Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.056290.
    PubMed     Abstract available

  39. MAJITHIA A, Bhatt DL, Friedman AN, Miller M, et al
    Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients with Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Circulation. 2021 Oct 28. doi: 10.1161/CIRCULATIONAHA.121.055560.
    PubMed     Abstract available

  40. KHAN SU, Javed Z, Lone AN, Dani SS, et al
    Social Vulnerability and Premature Cardiovascular Mortality Among US Counties, 2014 to 2018.
    Circulation. 2021;144:1272-1279.
    PubMed     Abstract available

  41. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
    Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
    PubMed     Abstract available

  42. HESS CN, Debus ES, Nehler MR, Anand SS, et al
    Reduction in Acute Limb Ischemia with Rivaroxaban versus Placebo in Peripheral Artery Disease after Lower Extremity Revascularization: Insights from VOYAGER PAD.
    Circulation. 2021 Oct 12. doi: 10.1161/CIRCULATIONAHA.121.055146.
    PubMed     Abstract available

    September 2021
  43. CHO SM, Mehaffey JH, Meyers SL, Cantor RS, et al
    Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Circulation. 2021;144:763-772.
    PubMed     Abstract available

    August 2021
  44. LAKKIREDDY D, Thaler D, Ellis CR, Swarup V, et al
    Circulation. 2021 Aug 30. doi: 10.1161/CIRCULATIONAHA.121.057063.
    PubMed     Abstract available

  45. LACKEY LG, Garnett CE, Senatore F
    Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMIS.
    Circulation. 2021;144:655-658.

  46. DEBUS ES, Nehler MR, Govsyeyev N, Bauersachs RM, et al
    Effect of Rivaroxaban and Aspirin in Patients with Peripheral Artery Disease Undergoing Surgical Revascularization: Insights from the VOYAGER PAD Trial.
    Circulation. 2021 Aug 12. doi: 10.1161/CIRCULATIONAHA.121.054835.
    PubMed     Abstract available

    July 2021
  47. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
    Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
    Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
    PubMed     Abstract available

    May 2021
  48. CRUMP C, Sundquist J, Sundquist K
    Preterm Delivery and Long-Term Risk of Stroke in Women: A National Cohort and Cosibling Study.
    Circulation. 2021 May 10. doi: 10.1161/CIRCULATIONAHA.120.052268.

    April 2021
  49. TRIFAN G, Gorelick PB, Testai FD
    Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Circulation. 2021 Apr 30. doi: 10.1161/CIRCULATIONAHA.121.053782.
    PubMed     Abstract available

  50. BENESCH C, Glance LG, Derdeyn CP, Fleisher LA, et al
    Perioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.
    Circulation. 2021 Apr 8:CIR0000000000000968. doi: 10.1161/CIR.0000000000000968.
    PubMed     Abstract available

  51. KAR S, Doshi SK, Sadhu A, Horton R, et al
    Primary Outcome Evaluation of a Next Generation Left Atrial Appendage Closure Device: Results from the PINNACLE FLX Trial.
    Circulation. 2021 Apr 6. doi: 10.1161/CIRCULATIONAHA.120.050117.
    PubMed     Abstract available

  52. DOUMOURAS A, Wong JA, Paterson JM, Lee Y, et al
    Bariatric Surgery and Cardiovascular Outcomes in Patients With Obesity and Cardiovascular Disease: A Population-Based Retrospective Cohort Study.
    Circulation. 2021 Apr 5. doi: 10.1161/CIRCULATIONAHA.120.052386.

    March 2021
  53. SALEH C
    Letter by Saleh Regarding Article, "Carotid Atherosclerosis Evolution When Targeting a Low-Density Lipoprotein Cholesterol Concentration <70 mg/dL After an Ischemic Stroke of Atherosclerotic Origin".
    Circulation. 2021;143:e790-e791.

    February 2021
  54. BUTALA NM, Makkar R, Secemsky EA, Gallup D, et al
    Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results from the TVT Registry.
    Circulation. 2021 Feb 23. doi: 10.1161/CIRCULATIONAHA.120.052874.
    PubMed     Abstract available

  55. GOFF DC JR, Khan SS, Lloyd-Jones D, Arnett DK, et al
    Bending the Curve in Cardiovascular Disease Mortality: Bethesda + 40 and Beyond.
    Circulation. 2021;143:837-851.
    PubMed     Abstract available

  56. ELGENDY IY, Bukhari S, Barakat AF, Pepine CJ, et al
    Maternal Stroke: A Call for Action.
    Circulation. 2021;143:727-738.
    PubMed     Abstract available

  57. RAGHUNATH S, Pfeifer JM, Ulloa-Cerna AE, Nemani A, et al
    Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead Electrocardiogram and Help Identify Those at Risk of AF-Related Stroke.
    Circulation. 2021 Feb 16. doi: 10.1161/CIRCULATIONAHA.120.047829.

    January 2021
  58. VIRANI SS, Alonso A, Aparicio HJ, Benjamin EJ, et al
    Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
    Circulation. 2021 Jan 27:CIR0000000000000950. doi: 10.1161/CIR.0000000000000950.
    PubMed     Abstract available

  59. BENJAMIN EJ, Go AS, Desvigne-Nickens P, Anderson CD, et al
    Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
    Circulation. 2021;143:372-388.
    PubMed     Abstract available

  60. HIJAZI Z, Alexander JH, Li Z, Wojdyla DM, et al
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients with Atrial Fibrillation After Acute Coronary Syndrome or PCI: Insights from The AUGUSTUS Trial.
    Circulation. 2021 Jan 19. doi: 10.1161/CIRCULATIONAHA.120.051020.
    PubMed     Abstract available

  61. LI W, Kessinger CW, Orii M, Lee H, et al
    Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
    Circulation. 2021 Jan 15. doi: 10.1161/CIRCULATIONAHA.120.049096.
    PubMed     Abstract available

  62. SCHWARTZ GG, Steg PG, Bhatt DL, Bittner VA, et al
    Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES Trial.
    Circulation. 2021 Jan 13. doi: 10.1161/CIRCULATIONAHA.120.049447.
    PubMed     Abstract available

    December 2020
  63. KATSANOS AH, Kamel H, Healey JS, Hart RG, et al
    Stroke Prevention in Atrial Fibrillation: Looking Forward.
    Circulation. 2020;142:2371-2388.
    PubMed     Abstract available

  64. CHURCHWELL K, Elkind MSV, Benjamin RM, Carson AP, et al
    Call to Action: Structural Racism as a Fundamental Driver of Health Disparities: A Presidential Advisory From the American Heart Association.
    Circulation. 2020;142:e454-e468.
    PubMed     Abstract available

  65. SOGAARD M, Nielsen PB, Skjoth F, Eldrup N, et al
    Temporal Changes in Secondary Prevention and Cardiovascular Outcomes after Revascularization for Peripheral Arterial Disease in Denmark: A Nationwide Cohort Study.
    Circulation. 2020 Dec 10. doi: 10.1161/CIRCULATIONAHA.120.047994.
    PubMed     Abstract available

  66. SAFFORD MM, Reshetnyak E, Sterling MR, Richman JS, et al
    Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Circulation. 2020 Dec 3. doi: 10.1161/CIRCULATIONAHA.120.048026.
    PubMed     Abstract available

    November 2020
  67. MARSTON NA, Patel PN, Kamanu FK, Nordio F, et al
    Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease.
    Circulation. 2020 Nov 13. doi: 10.1161/CIRCULATIONAHA.120.051927.
    PubMed     Abstract available

    October 2020
  68. AYTEKIN A, Ndrepepa G, Neumann FJ, Menichelli M, et al
    Ticagrelor or Prasugrel in Patients with ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Circulation. 2020 Oct 29. doi: 10.1161/CIRCULATIONAHA.120.050244.
    PubMed     Abstract available

  69. LOWENSTEIN CJ, Solomon SD
    Severe COVID-19 Is a Microvascular Disease.
    Circulation. 2020;142:1609-1611.

  70. MODIN D, Claggett B, Sindet-Pedersen C, Lassen MCH, et al
    Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.050809.

  71. TAMBURINO C, Bleiziffer S, Thiele H, Scholtz S, et al
    Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
    Circulation. 2020 Oct 15. doi: 10.1161/CIRCULATIONAHA.120.051547.
    PubMed     Abstract available

  72. BENEDETTO U, Gaudino MF, Dimagli A, Gerry S, et al
    Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.
    Circulation. 2020;142:1320-1329.
    PubMed     Abstract available

  73. DROBNI ZD, Alvi RM, Taron J, Zafar A, et al
    Association Between Immune Checkpoint Inhibitors with Cardiovascular Events and Atherosclerotic Plaque.
    Circulation. 2020 Oct 2. doi: 10.1161/CIRCULATIONAHA.120.049981.
    PubMed     Abstract available

    August 2020
  74. GAUDINO M, Benesch C, Bakaeen F, DeAnda A, et al
    Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Aug 26:CIR0000000000000885. doi: 10.1161/CIR.0000000000000885.
    PubMed     Abstract available

    July 2020
  75. LIBERALE L, Bonetti NR, Puspitasari YM, Schwarz L, et al
    Postischemic Administration of IL-1alpha Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke.
    Circulation. 2020;142:187-189.

    June 2020
  76. WILLEIT P, Tschiderer L, Allara E, Reuber K, et al
    Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100,667 Patients.
    Circulation. 2020 Jun 17. doi: 10.1161/CIRCULATIONAHA.120.046361.
    PubMed     Abstract available

  77. LEE H, Yano Y, Cho SMJ, Park JH, et al
    Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Circulation. 2020;141:1778-1786.
    PubMed     Abstract available

    May 2020
  78. YANG L, Han B, Zhang Z, Wang S, et al
    Extracellular Vesicle-Mediated Delivery of CircSCMH1 Promotes Functional Recovery in Rodent and Nonhuman Primate Ischemic Stroke Models.
    Circulation. 2020 May 22. doi: 10.1161/CIRCULATIONAHA.120.045765.
    PubMed     Abstract available

    Screening for Atrial Fibrillation: Closing the "LOOP".
    Circulation. 2020;141:1523-1526.

    April 2020
  80. BETHEL MA, Stevens SR, Buse JB, Choi J, et al
    Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes.
    Circulation. 2020;141:1360-1370.
    PubMed     Abstract available

  81. CAINZOS-ACHIRICA M, Miedema MD, McEvoy JW, Al Rifai M, et al
    Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2020 Apr 1. doi: 10.1161/CIRCULATIONAHA.119.045010.
    PubMed     Abstract available

    March 2020
  82. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available

  83. KAPLAN RM, Ziegler PD, Passman RS
    Response by Kaplan et al to Letter Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e599-e600.

  84. CAO S, Zhu X, Xia M
    Letter by Cao et al Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e597-e598.

    February 2020
  85. HARRINGTON RA, Califf RM, Balamurugan A, Brown N, et al
    Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association.
    Circulation. 2020 Feb 10:CIR0000000000000753. doi: 10.1161/CIR.0000000000000753.
    PubMed     Abstract available

    January 2020
  86. VIRANI SS, Alonso A, Benjamin EJ, Bittencourt MS, et al
    Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.
    Circulation. 2020 Jan 29:CIR0000000000000757. doi: 10.1161/CIR.0000000000000757.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.